Recent genomic studies have actually provided a more accurate picture of the heterogeneous and complex mutation landscape of the CML disease beyond BCR::ABL1 throughout the disease course (see also the paragraph “Somatic mutations”). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.